product portfolio:
prostrate cancer,
breast cancer,
melanoma,
leukemia,
pancreatic cancer,
the pill plus contraception - all in late human clinical,
colorectal and melanoma in early human clinical.
elestrin in late human clinical and partnered with Azur Phar.,
Bio-T-Gel partnered with Teva and FDA approved,
Cancer Vaccine in late human clinical and with John Hopkins, Aduro Dio Tech,
Libel Gel in late human clinical.